Explore 3 Stock Ideas & Industry Insights Download Free Report
Vital Farms Inc

VITL Details
Vital Farms Inc (Nasdaq: VITL) is one of the top U.S. brands of pasture-raised eggs and pasture-raised butter. It is also the second-largest egg brand in terms of retail dollar sales. The company sold its pasture-raised eggs and butter products across conventional and natural grocery stores and foodservice outlets in the country.

Results Performance for the Second Quarter Ended 27 June 2021 (Q2FY21)

Key Data (Source: Company Reports)
Recent Update
Outlook
The management believes that there might not be further substantial disruptions to the supply chain or customers or adverse changes in macroeconomic factors. Resultantly, the company's management has guided achieving net revenue in the range of $246-$253 million in FY21, a growth of 15-18% compared to 2020. Further, it has maintained its guidance on its adjusted EBITDA that is expected to remain between $7-$9 million in FY21. Meanwhile, the company will release its financial results for Q3FY21 on November 9, 2021.
Key Risks
The company’s inability to launch new products may hurt its growth plans. VITL’s performance depends on pasture-raised shell eggs, and any slowdown in these sales would negatively impact its financial condition. Volatility in commodity prices and the availability of feed grains could have a bearing on its results.
Valuation Methodology: EV/Sales Based Relative Valuation (Illustrative)

Technical Overview
Daily Price Chart

Source: REFINITIV, Note: Purple color line reflects Relative Strength Index (14-Period)

Stock Recommendation
The stock declined by ~36.87% in 9 months. The stock has been valued using an EV/Sales multiple based relative valuation (on an illustrative basis) and the target price so arrived reflects a rise of low double-digit (in % terms). A slight premium has been applied to peer average EV/Sales multiple (NTM basis) considering increased current ratio in Q2FY21 on the YoY basis as well as decent outlook.
Considering the aforementioned factors, we give a “Speculative Buy” recommendation on the stock at the closing market price of $16.50 per share, down by 4.07% as of 27th October 2021.
Note 1: The reference data in this report has been partly sourced from REFINITIV.
Note 2: Investment decisions should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the analysis has been achieved and subject to the factors discussed above alongside support levels provided.
Technical Indicators Defined:-
Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.
Resistance: A level where-in the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices
Disclaimer
References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.
This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.
The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.
Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.
Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Past performance is not a reliable indicator of future performance.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…